Ovarian Cancer: Low Dose Naltrexone as a Possible Treatment
The following research article on PubMed concluded Low Dose Natrexone (LDN) to be a beneficial treatment option for ovarian cancer. The following results were stated:
“These preclinical data may offer a non-toxic and efficacious pathway-related treatment that can benefit patients with ovarian cancer.”
CLICK HERE to read more